Dalton Lisa 4
4 · Nabriva Therapeutics plc · Filed Jun 4, 2021
Insider Transaction Report
Form 4
Dalton Lisa
Director
Transactions
- Award
Share Options
2021-06-02+10,500→ 10,500 totalExercise: $1.39Exp: 2031-06-01→ Ordinary Shares (10,500 underlying)
Footnotes (2)
- [F1]The option was granted on June 2, 2021.
- [F2]The option will vest over a three-year period on a monthly pro rata basis beginning on June 2, 2021 and subject to the Reporting Person's continued service on the board of directors of the Issuer.